Myo-inositol Administration in Gestational Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00734448 |
Recruitment Status
: Unknown
Verified June 2014 by Rosario D'anna, University of Messina.
Recruitment status was: Recruiting
First Posted
: August 14, 2008
Last Update Posted
: June 13, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Gestational Diabetes Mellitus | Dietary Supplement: myo-inositol | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 30 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Effect of Myo-inositol Administration on Insulin Sensitivity in Gestational Diabetes Patients by Continuous Glucose Monitoring System (CGMS) |
Study Start Date : | November 2013 |
Estimated Primary Completion Date : | November 2014 |
Estimated Study Completion Date : | December 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: A,1
Gestational diabetes patients who take myo-inositol
|
Dietary Supplement: myo-inositol
2 g twice a day until delivery
|
- Insulin sensitivity index (HOMA-IR) and continuous glucose monitoring profile [ Time Frame: Change from baseline in HOMA-IR at 8 weeks of treatment ]
- baby weight at delivery [ Time Frame: After delivery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 44 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Gestational diabetes diagnosed within 28 weeks
- Caucasian pregnant women
Exclusion Criteria:
- Non Caucasian pregnant women
- Delivery before 8 weeks of treatment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00734448
Contact: rosario d'anna, professor | 39-090-2211 ext 3809 | rosariodanna@tin.it |
Italy | |
University of Messina - | Recruiting |
Messina, Sicilia, Italy, 98100 | |
Contact: francesco corrado, researcher 39-090-2211 ext 2176 francesco.corrado@unime.it | |
Principal Investigator: rosario d'anna, professor | |
Sub-Investigator: francesco corrado, researcher |
Principal Investigator: | Rosario D'Anna, professor | University of Messina, ITALY |
Responsible Party: | Rosario D'anna, associate professor, University of Messina |
ClinicalTrials.gov Identifier: | NCT00734448 History of Changes |
Other Study ID Numbers: |
Myo-1954 |
First Posted: | August 14, 2008 Key Record Dates |
Last Update Posted: | June 13, 2014 |
Last Verified: | June 2014 |
Keywords provided by Rosario D'anna, University of Messina:
gestational diabetes mellitus carbohydrate intolerance myo-inositol insulin resistance |
Additional relevant MeSH terms:
Diabetes Mellitus Diabetes, Gestational Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Pregnancy Complications |
Inositol Vitamin B Complex Vitamins Micronutrients Growth Substances Physiological Effects of Drugs |